Amit Agarwal

Amit Agarwal is a Managing Director at Deloitte Consulting, leading the Next Generation Cell & Gene Therapy Practice on the West Coast since November 2011, following a tenure as Principal in the Life Science and Healthcare Practice. Previous experience includes serving as a Partner at Scientia Advisors, focusing on growth strategies for life sciences companies, and as Vice President at Leerink Swann & Company, where Amit facilitated acquisitions in the life sciences sector. Additional roles encompass Principal at A.T. Kearney, VP at marchFirst, Partner at Mitchell Madison Group, and Managing Consultant at Gemini Consulting. Early career endeavors include diplomatic service at the US Department of State and a research assistant position at the California Institute of Technology. Amit Agarwal holds an MBA in Finance and Technological Innovation from MIT Sloan School of Management, along with certificates in Arabic and Chinese Language and Area Studies from the Foreign Service Institute, and a Bachelor's degree in History and Pre-med from Occidental College.